NL-OMON29589已完成不适用
Renal toxicity during angiogenesis inhibition:predicting factors, early detection and timely treatment
Dr. M.H.W. Kappers, Amphia hospital Breda0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with malignancy treated with an anti-VEGF monoclonal antibody or receptor tyrosine kinase inhibitor (RTKI) + chemotherapy
- •- Patients treated with chemotherapy alone (without an anti-VEGF monoclonal antibody or RTKI) = control group 1
排除标准
- •- Healthy controls (control group 2) with abnormal kidney function and/or proteinuria (protein-to-creatinine ratio > 45 mg/mmol or albumin-to-creatinine ratio > 30 mg/mmol)
- •- Known renal insufficiency (MDRD < 60 ml/min) in patients with malignancy and/or proteinuria (protein-to-creatinine ratio > 45 mg/mmol or albumin-to-creatinine ratio > 30 mg/mmol) if this latter has been previously reported
研究者
相似试验
已完成
2 期
Acute Renal effects of Angiotensin II Management In Shock in the Intensive Care Unit (ARAMIS-ICU)Distributive shockRenal and Urogenital - Kidney diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12621000281897Austin Health160
进行中（未招募）
不适用
Effect of angiogenesis inhibiting therapy in patients progressing on endocrine treatment and patients with triple negative breast cancer - a translational phase II study within theSwedish Association of Breast Oncologists SABO-2010-01Patients with breast cancer who are oestrogen receptor positive but HER2 negative and progressing on endocrine therapy. Patients with locally advanced or recurrent triple negative breast cancer (TNBC) can also be included. Patients with TNBC will not receive endocrine therapy.MedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022065-10-SESahlgrenska University Hospital
已完成
3 期
A study to determine the feasibility of a trial investigating the effect of angiotensin II infusion on kidney damage in cardiac surgical patientsAcute kidney injuryAnaesthesiology - Other anaesthesiologySurgery - Other surgeryCardiovascular - Other cardiovascular diseasesRenal and Urogenital - Kidney diseaseACTRN12621000195853Austin Health60
招募中
Unknown
ew Calculation Parameter(Modified Renal Angina Index) For Prediction Of Kidney Outcomes in Intensive Care UnitsCTRI/2023/04/051884ot Applicable
已完成
不适用
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30